1-4 of 4
Peter Hinderlie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

Zachary Davis, Martin Felices, Todd Lenvik, Sujan Badal, Joshua T. Walker, Peter Hinderlie, James L. Riley, Daniel A. Vallera, Bruce R. Blazar, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1069–1080.
https://doi.org/10.1182/bloodadvances.2019001110
Published: 2021
Includes: Supplemental data
Journal Articles

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL

Martin Felices, Behiye Kodal, Peter Hinderlie, Michael F. Kaminski, Sarah Cooley, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller, Veronika Bachanova
Journal: Blood Advances
Blood Adv (2019) 3 (6): 897–907.
https://doi.org/10.1182/bloodadvances.2018029371
Published: 2019
Includes: Supplemental data
Journal Articles

Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells

Hyun Don Yun, Martin Felices, Daniel A. Vallera, Peter Hinderlie, Sarah Cooley, Michel Arock, Jason Gotlib, Celalettin Ustun, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1580–1584.
https://doi.org/10.1182/bloodadvances.2018018176
Published: 2018
Includes: Supplemental data
Journal Articles

161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS

Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall, Todd Lenvik, Peter Hinderlie, Julie Curtsinger, Erica Warlick, Stephen R. Spellman, Bruce R. Blazar, Daniel J. Weisdorf, Sarah Cooley, Daniel A. Vallera, Björn Önfelt, Jeffrey S. Miller
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1459–1469.
https://doi.org/10.1182/bloodadvances.2017012369
Published: 2018
Includes: Multimedia, Supplemental data